Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure (CACT-IHF)
Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure (CACT-IHF) A Randomized, Double-blind, Multicenter, Placebo-controlled Trial
Sponsor: State Administration of Traditional Chinese Medicine of the People's Republic of China
This NA trial investigates Ischemic Heart Failure and is currently ongoing. State Administration of Traditional Chinese Medicine of the People's Republic of China leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- State Administration of Traditional Chinese Medicine of the People's Republic of China
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Anhui, China , Baoding, China , Beijing, China , Changchun, China , Chengdu, China , Guangdong, China , Guiyang, China , Heilongjiang, China , Hengyang, China , Nanchang, China and 9 more locations